During the past decade, Hôpital Gui de Chauliac conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 31 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 18 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Gui de Chauliac" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 17 trials, followed by "University Hospital, Montpellier" with 15 trials sponsored, "ANRS, Emerging Infectious Diseases" with 8 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Stryker Neurovascular" with 5 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Gui de Chauliac" #1 collaborator was "Biogen" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Association Française contre les Myopathies (AFM), Paris" with 1 trials as a collaborator and "Caisse Nationale de Solidarité pour l'Autonomie" with 1 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Gui de Chauliac" are "Amyotrophic Lateral Sclerosis" (10 trials), "Alzheimer Disease" (9 trials), "Intracranial Aneurysm" (9 trials), "Multiple Sclerosis" (7 trials) and "HIV Infections" (6 trials). Many other conditions were trialed in "Hôpital Gui de Chauliac" in a lesser frequency.

Most popular intervention types in "Hôpital Gui de Chauliac" are "Drug" (70 trials), "Other" (30 trials), "Device" (15 trials), "Procedure" (12 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "placebo" (4 trials), "BI 409306" (2 trials), "Best Medical Therapy" (2 trials) and "Dexpramipexole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Gui de Chauliac" are 134 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Gui de Chauliac". 4 are not yet recruiting, 20 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Hôpital Gui de Chauliac, 2 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Gui de Chauliac, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 28 trials that are defined as “Not Applicable".